ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 188 filers reported holding ADMA BIOLOGICS INC in Q3 2023. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $165,500 | +347.3% | 50,000 | +233.3% | 0.00% | +200.0% |
Q3 2022 | $37,000 | -96.0% | 15,000 | -96.8% | 0.00% | -96.4% |
Q2 2022 | $929,000 | -85.5% | 469,206 | -86.6% | 0.03% | -87.4% |
Q1 2022 | $6,389,000 | +36.7% | 3,491,524 | +5.3% | 0.22% | +65.7% |
Q4 2021 | $4,675,000 | +253.9% | 3,315,607 | +341.9% | 0.13% | +127.1% |
Q1 2021 | $1,321,000 | – | 750,325 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 8,793,321 | $32,447,354 | 11.70% |
Velan Capital Investment Management LP | 2,726,051 | $10,059,128 | 9.34% |
Altium Capital Management LP | 2,380,000 | $8,782,200 | 6.65% |
AWM Investment Company, Inc. | 6,017,572 | $22,204,841 | 3.01% |
Caligan Partners LP | 847,513 | $3,127,323 | 1.76% |
Perceptive Advisors | 11,900,255 | $43,911,941 | 1.27% |
Mesirow Financial Investment Management, Inc. | 51,686 | $190,721 | 0.81% |
OBERWEIS ASSET MANAGEMENT INC/ | 1,668,700 | $6,157,503 | 0.75% |
TANG CAPITAL MANAGEMENT LLC | 1,260,000 | $4,649,400 | 0.68% |
EAM Investors, LLC | 883,842 | $3,261,377 | 0.60% |